108 search results for: symposium

ADVENT at EADV 2026
Congress
29
September
2026
Congress
ADVENT at EADV 2026

Please join the ADVENT program at EADV 2026 for educational sessions on AD, PN, and CSU!

 

UEGW 2024 | Latest Clinical Evidence for Biologics in EoE
Gastroenterology
UEGW 2024 | Latest Clinical Evidence for Biologics in EoE
expert video

Prof. Salvatore Oliva discusses the latest clinical data for EoE that included patients from childhood to adulthood.

View more
UEGW 2024 | WHAT Can Be Used to Monitor Treatment Response in EoE and WHEN?
Gastroenterology
UEGW 2024 | WHAT Can Be Used to Monitor Treatment Response in EoE and WHEN?
expert video

Dr. Milli Gupta emphasizes the need to regularly monitor multiple disease domains when assessing treatment response, not just EoE symptoms.

View more
UEGW 2024 | WHY Is Long-Term Management of EoE Important?
Gastroenterology
UEGW 2024 | WHY Is Long-Term Management of EoE Important?
expert video

Prof. Salvatore Oliva discusses the impact of chronic type 2 inflammation on EoE progression, highlighting the need for long-term management.

View more
A Tale of Two Itches: Bridging the Gap With Type 2 Inflammation in PN and CSU
Congress
11
March
2024
Congress
A Tale of Two Itches: Bridging the Gap With Type 2 Inflammation in PN and CSU

Join Drs. Elmariah, Kim, and Metz as they explore the latest research on neuro-immune mechanisms driving chronic itch and inflammation in PN and CSU.

UEGW 2024 | Something to Chew On: Exploring Biologics in EoE Management
Gastroenterology
UEGW 2024 | Something to Chew On: Exploring Biologics in EoE Management
expert video

Prof. Salvatore Oliva and Dr. Milli Gupta discuss the importance of long-term care, multidimensional assessment, and the latest data for biologics.

View more
GUF PNG
Congress
4
December
2024
Congress
Translating the Science of CSU: From Pathogenesis to Patient Outcomes

Join Drs. Michihiro Hide, Marta Ferrrer, and Ana M. Giménez-Arnau as they discuss chronic spontaneous urticaria (CSU) and highlight the unmet needs, treatment challenges, and emerging therapies.